Pubblicazioni

  • Home
  • Pubblicazioni
 
Evaluation of T and B lymphocytopenia in patients treated with ocrelizumab switching from other treatments compared to naive
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Injectable versus oral first-line disease-modifying therapies: results from italian ms register
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Is antibody titer useful to verify the immunization after VZV Vaccine in MS patients treated with Fingolimod? A case series
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Italian consensus on treatment of spasticity in multiple sclerosis
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Italian prospective multicentric observational real-life study of aggressive relapsing remitting multiple sclerosis treated with alemtuzumab
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Motor disability assessment in the Google Maps era: a feasibility study to test a digital tool
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Mri activity and extended interval of natalizumab dosing: a multicenter italian study
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Ocrelizumab in a case of refractory chronic inflammatory demyelinating polyneuropathy with anti-rituximab antibodies
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Risks associated with wash-out duration when switching from fingolimod to cell-depleting agents
Giacomo Lus
Giacomo Lus
Vai all’articolo »